German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms

AstraZeneca

Status: Completed

Conditions: Gastroesophageal Reflux

Study type: Observational

Funder types: Industry

Identifiers

NCT00567021

German PMS trial no.7

1312004007

Details and patient eligibility

About

This PMS study had the objective to evaluate under ordinary medical care conditions the efficacy and tolerability of esomeprazole in patients who where treated by general practitioners and internists.

Enrollment: 67,130 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with GERD, or NSAID related ulcers, who need treatment with esomeprazole.

Exclusion criteria

• Limitations; possible risks; warnings; contraindications mentioned in the SPC.

Trial design

67,130 participants in 1 patient group

1

Description:

patients with GERD or NSAID-related ulcers